Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients ; volume:7 ; number:1 ; day:20 ; month:2 ; year:2019 ; pages:1-12 ; date:12.2019
Journal for ImmunoTherapy of Cancer ; 7, Heft 1 (20.2.2019), 1-12, 12.2019
- Creator
-
Fässler, Mirjam
Diem, Stefan
Mangana, Joanna
Hasan Ali, Omar
Berner, Fiamma
Bomze, David
Ring, Sandra
Niederer, Rebekka
del Carmen Gil Cruz, Cristina
Pérez Shibayama, Christian Ivan
Krolik, Michal
Siano, Marco
Joerger, Markus
Recher, Mike
Risch, Lorenz
Güsewell, Sabine
Risch, Martin
Speiser, Daniel E.
Ludewig, Burkhard
Levesque, Mitchell P.
Dummer, Reinhard
Flatz, Lukas
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40425-019-0523-2
- URN
-
urn:nbn:de:101:1-2019032019503929971735
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Fässler, Mirjam
- Diem, Stefan
- Mangana, Joanna
- Hasan Ali, Omar
- Berner, Fiamma
- Bomze, David
- Ring, Sandra
- Niederer, Rebekka
- del Carmen Gil Cruz, Cristina
- Pérez Shibayama, Christian Ivan
- Krolik, Michal
- Siano, Marco
- Joerger, Markus
- Recher, Mike
- Risch, Lorenz
- Güsewell, Sabine
- Risch, Martin
- Speiser, Daniel E.
- Ludewig, Burkhard
- Levesque, Mitchell P.
- Dummer, Reinhard
- Flatz, Lukas
- SpringerLink (Online service)
Other Objects (12)
Antidepressant activated biochemical pathways and biomarker candidates
Antidepressant activated biochemical pathways and biomarker candidates
Distinct predictive biomarker candidates for response to anti-CTLA-4 and anti-PD-1 immunotherapy in melanoma patients
Identification of biomarker candidates for exfoliative glaucoma from autoimmunity profiling
The Role of Immune Checkpoint Blockade in Uveal Melanoma
Novel epigenetic and genetic biomarker candidates in post-traumatic stress disorder
Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis
Molecular patterns of resistance to immune checkpoint blockade in melanoma
Combined checkpoint inhibitor therapy causing diabetic ketoacidosis in metastatic melanoma
Predictors of responses to immune checkpoint blockade in advanced melanoma
Exploring gene expression biomarker candidates for neurobehavioral impairment from total sleep deprivation
H3K27me3 and EZH2 expression in melanoma: relevance for melanoma progression and response to immune checkpoint blockade
Antidepressant activated biochemical pathways and biomarker candidates
Antidepressant activated biochemical pathways and biomarker candidates
Distinct predictive biomarker candidates for response to anti-CTLA-4 and anti-PD-1 immunotherapy in melanoma patients
Identification of biomarker candidates for exfoliative glaucoma from autoimmunity profiling
The Role of Immune Checkpoint Blockade in Uveal Melanoma
Novel epigenetic and genetic biomarker candidates in post-traumatic stress disorder
Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis
Molecular patterns of resistance to immune checkpoint blockade in melanoma
Combined checkpoint inhibitor therapy causing diabetic ketoacidosis in metastatic melanoma
Predictors of responses to immune checkpoint blockade in advanced melanoma
Exploring gene expression biomarker candidates for neurobehavioral impairment from total sleep deprivation
H3K27me3 and EZH2 expression in melanoma: relevance for melanoma progression and response to immune checkpoint blockade
Antidepressant activated biochemical pathways and biomarker candidates
Antidepressant activated biochemical pathways and biomarker candidates
Distinct predictive biomarker candidates for response to anti-CTLA-4 and anti-PD-1 immunotherapy in melanoma patients
Identification of biomarker candidates for exfoliative glaucoma from autoimmunity profiling
The Role of Immune Checkpoint Blockade in Uveal Melanoma
Novel epigenetic and genetic biomarker candidates in post-traumatic stress disorder
Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis
Molecular patterns of resistance to immune checkpoint blockade in melanoma
Combined checkpoint inhibitor therapy causing diabetic ketoacidosis in metastatic melanoma
Predictors of responses to immune checkpoint blockade in advanced melanoma
Exploring gene expression biomarker candidates for neurobehavioral impairment from total sleep deprivation